Rationale for and design of the SUBQ-HF clinical study.
Event:
HEART FAILURE 2016
Congress Presentation
About the speaker
Professor G Michael Felker
Duke Clinical Research Institute, Durham (United States of America)
14
presentations
0
follower
3 more presentations in this session
Furosemide 2.0: a novel formulation of furosemide for subcutaneous administration.
Speaker: Professor B. Pitt (Ann Arbor, US)
Pharmacokinetics of furosemide following subcutaneous administration of a novel injectable formulation.
Speaker: Professor R. De Boer (Rotterdam, NL)
Initial clinical experience with subcutaneous furosemide in patients with fluid overload.
Speaker: Doctor S. Russell (Durham, US)
Access the full session
Furosemide 2.0: furosemide for subcutaneous administration: a novel tool in the management of the pre and post acute heart failure patient
Speakers:
Professor G. Felker, Professor B. Pitt, Professor R. De Boer, Doctor S. Russell
About the event
ESC 365 is supported by
